Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation

Elizabeth Ann Emmel(Howard Hughes Medical Institute), Cornelis L. Verweij(Howard Hughes Medical Institute), David B. Durand(Howard Hughes Medical Institute), Kay M. Higgins(Memorial Sloan Kettering Cancer Center), Elizabeth Lacy(Memorial Sloan Kettering Cancer Center), Gerald R. Crabtree(Howard Hughes Medical Institute)
Science
December 22, 1989
Cited by 678

Abstract

One action of cyclosporin A thought to be central to many of its immunosuppressive effects is its ability to inhibit the early events of T lymphocyte activation such as lymphokine gene transcription in response to signals initiated at the antigen receptor. Cyclosporin A was found to specifically inhibit the appearance of DNA binding activity of NF-AT, AP-3, and to a lesser extent NF-kappa B, nuclear proteins that appear to be important in the transcriptional activation of the genes for interleukin-2 and its receptor, as well as several other lymphokines. In addition, cyclosporin A abolished the ability of the NF-AT binding site to activate a linked promoter in transfected mitogen-stimulated T lymphocytes and in lymphocytes from transgenic mice. These results indicate that cyclosporin A either directly inhibits the function of nuclear proteins critical to T lymphocyte activation or inhibits the action of a more proximal member of the signal transmission cascade leading from the antigen receptor to the nucleus.


Related Papers

No related papers found

Powered by citation graph analysis